Lyra Therapeutics - Lyra Therapeutics
4.9 (175) · € 22.99 · En Stock
We are pioneering a new therapeutic approach to treat debilitating ear, nose and throat (ENT) diseases that impact the lives of millions of people.
Lyra Therapeutics - Lyra Therapeutics
Pipeline - Lyra Therapeutics
Lyra Therapeutics Adds Vineeta Belanger, Ph.D., as Senior Vice President of Clinical Affairs
Investor Relations - Lyra Therapeutics, Inc.
Lyra Therapeutics raises $29.5M for chronic rhinosinusitis drug implant - MedCity News
Lyra Therapeutics - Lyra Therapeutics
Lyra Therapeutics enrolls first patient in rhinosinusitis trial
Lyra Therapeutics
SEC Filing - Lyra Therapeutics, Inc.
Lyra Therapeutics: Progress In The Clinic (NASDAQ:LYRA)
Lyra Therapeutics - Lyra Therapeutics
Lyra Therapeutics appoints Richard Nieman as CMO - Medical Buyer
Lyra Therapeutics (LYRA) Investor Presentation - Slideshow (NASDAQ:LYRA)
Is Lyra Therapeutics (NASDAQ:LYRA) In A Good Position To Deliver On Growth Plans?
